8-K: InMed Pharmaceuticals Inc. Cancels and Reschedules Special Shareholder Meeting
Current Report
InMed Pharmaceuticals Inc. announces the cancellation of the original notice for its special shareholder meeting and provides details for the rescheduled meeting.
Summary
- InMed Pharmaceuticals Inc. has cancelled its previously announced special meeting of shareholders.
- The company's agent, Odyssey Trust Company, filed an amendment to the original notice with Canadian securities authorities on SEDAR+ to reflect this cancellation.
- A new meeting date has been set for June 13, 2025.
- The record date for notice of the meeting and for voting is April 29, 2025.
- The beneficial ownership determination date is also April 29, 2025.
- Common shares are the class of securities entitled to vote.
Sentiment
Score: 5
Explanation: The announcement is neutral in sentiment as it simply communicates a change in the date of a shareholder meeting.
Industry Context
The announcement relates to corporate governance procedures, specifically the scheduling and notification of shareholder meetings, which are standard practices for publicly traded companies.
Key Dates
| Date | Description |
|---|---|
| April 25, 2025 | Date of report and filing of amended notice. |
| April 29, 2025 | Record date for notice of meeting, voting, and beneficial ownership determination. |
| June 13, 2025 | Rescheduled date for the special meeting of securityholders. |
Keywords
special meeting, shareholders, InMed Pharmaceuticals, meeting, notice, record date
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.